Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid

BACKGROUND: Determination of β-amyloid (Aβ) positivity and likelihood of underlying Alzheimer’s disease (AD) relies on dichotomous biomarker cut-off values. Individuals with mild cognitive impairment (MCI) and Aβ within the normal range may still have a substantial risk of developing dementia, prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Anna, Solomon, Alina, Jelic, Vesna, Hagman, Göran, Bogdanovic, Nenad, Kivipelto, Miia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896336/
https://www.ncbi.nlm.nih.gov/pubmed/31805990
http://dx.doi.org/10.1186/s13195-019-0557-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896336/
https://www.ncbi.nlm.nih.gov/pubmed/31805990
http://dx.doi.org/10.1186/s13195-019-0557-1

Ejemplares similares